Arcturus Therapeutics has built a multicultural team, based in San Diego, CA, USA
We have an exciting COVID-19 vaccine candidate that we hope will make a positive difference in the pandemic
See our team describe what it means for them to help get a vaccine to protect people around the world-no matter where you are from
A
S
L
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/JoePayne_LanguageProficiency_V3_1.mp4?time=1643119481
arabic
(عربى)
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/MaherA_LanguageProficiency_V3_1.mp4?time=1643119481
chinese
(中文)
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_BelleBao.jpg?time=1643119481,https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/BelleBao_LanguageProficiency__V3_1.mp4?time=1643119481
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_HowardYu.jpg?time=1643119481,https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/HowardYu_LanguageProficiency_V3_1.mp4?time=1643119481
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_YurongGuo.jpg?time=1643119481,https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/YurongGuo_LanguageProficiency_V3_1.mp4?time=1643119481
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_XuefengGuo.jpg?time=1643119481,https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/XuefengGuo_LanguageProficiency_V3_1.mp4?time=1643119481
english
(British)
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/MikeHodges_LanguageProficiency_V3_1.mp4?time=1643119481
farsi
(فارسی)
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2021/01/NedaSafarzadeh_LanguageProficiency_V4.mp4?time=1643119481
french
(Français)
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/NadjaEl-mecharrafie_LanguageProficiency_V3_1.mp4?time=1643119481
german
(deutsch)
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/LisaKieweg-Thompson_LanguageProficiency_V3_1.mp4?time=1643119481
hebrew
(עִברִית)
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_NoaScott.jpg?time=1643119481,https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/NoaScott_LanguageProficiency_V3_1.mp4?time=1643119481
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_TamarGrossman.jpg?time=1643119481,https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/TamarGrossman_LanguageProficiency_V3_1.mp4?time=1643119481
hindi
(हिन्दी)
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/PriyaKarmali_LanguageProficiency_V3_1.mp4?time=1643119481
italian
(italiano)
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_CristianoSacchetti.jpg?time=1643119481,https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/CristianoSacchetti_LanguageProficiency_V3_1.mp4?time=1643119481
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_GiulioCattarossi.jpg?time=1643119481,https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/GiulioCattarossi_LanguageProficiency_V3_1.mp4?time=1643119481
Japanese
(日本語)
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/09/Kiyoshi_Tachikawa_v2.mp4?time=1643119481
korean
(한국어)
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/JaeHeonKim_LanguageProficiency_V3_1.mp4?time=1643119481
portuguese
(Português)
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/RamonDiazTrelles_LanguageProficiency_V3_1.mp4?time=1643119481
spanish
(español)
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/CarlosPerezGarcia_LanguageProficiency__V3_1.mp4?time=1643119481
vietnamese
(Tiếng Việt)
https://secureservercdn.net/45.40.151.233/e32.83a.myftpupload.com/wp-content/uploads/2020/07/HannahHuynh_LanguageProficiency_V3_1.mp4?time=1643119481

Our Team

Grishma Acharya, Senior Manager, In Vivo Pharmacology
Grishma Acharya, Senior Manager, In Vivo Pharmacology
Jocelyn Agliam, Administrative Assistant
Jocelyn Agliam, Administrative Assistant
Suzan Alayian, Accounts Payable Specialist
Suzan Alayian, Accounts Payable Specialist
Maher Alayyoubi, Principal Scientist, Drug Substance
Maher Alayyoubi, Principal Scientist, Drug Substance
Ray Ahn , Senior Manager, Analytical Development
Ray Ahn , Senior Manager, Analytical Development
Claudia Averbuj , Associate Director, Chemistry
Claudia Averbuj , Associate Director, Chemistry
James Barlow, Director of the Board
James Barlow, Director of the BoardBio
Dina Berdieva, Vice President, Clinical Operations
Dina Berdieva, Vice President, Clinical OperationsBio
Stefen Boehme , Director, Head of Drug Discovery
Stefen Boehme , Director, Head of Drug Discovery
Babette de Boer , Principal Scientist, Toxicology
Babette de Boer , Principal Scientist, Toxicology
Natasha Bowman, Senior Vice President, Head of Human Resources
Natasha Bowman, Senior Vice President, Head of Human ResourcesBio
Juthamart Brady, Research Associate, Drug Discovery
Juthamart Brady, Research Associate, Drug Discovery
Gabbi Caporusso , Clinical Development Associate
Gabbi Caporusso , Clinical Development Associate
Giulio Cattarossi, Senior Research Associate, RNA Sciences
Giulio Cattarossi, Senior Research Associate, RNA Sciences
Lena Ceballos, Public Relations & Marketing Specialist
Lena Ceballos, Public Relations & Marketing Specialist
Pad Chivukula, CSO, COO
Pad Chivukula, CSO, COOBio
Jenny (Park) Choi , Senior Scientist
Jenny (Park) Choi , Senior Scientist
Brenda Clemente, Senior Manager, Formulation & Process Development
Brenda Clemente, Senior Manager, Formulation & Process Development
Lucas Del Cid, Associate Director, Program Management
Lucas Del Cid, Associate Director, Program Management
Diana Correa, Research Associate I, Analytical Development
Diana Correa, Research Associate I, Analytical Development
Connie Crowley , Executive Director, Senior Clinical Scientist
Connie Crowley , Executive Director, Senior Clinical Scientist
Alex Daily, Purchasing Manager
Alex Daily, Purchasing Manager
ThanhChau Dam, Senior Research Associate II, In Vivo Pharmacology
ThanhChau Dam, Senior Research Associate II, In Vivo Pharmacology
Michael Davis  , Research Associate I, Formulation Development
Michael Davis , Research Associate I, Formulation Development
Michael Delbuono, Research Associate I, Analytical Development
Michael Delbuono, Research Associate I, Analytical Development
Yisong Deng, Scientist II, Analytical Development
Yisong Deng, Scientist II, Analytical Development
Agustina D'Urso , Scientist I, Frontier Science
Agustina D'Urso , Scientist I, Frontier Science
Nadja El-Mecharrafie, Senior Research Associate I, Frontier Science
Nadja El-Mecharrafie, Senior Research Associate I, Frontier Science
Michael Endow , Research Associate I, Drug Substance
Michael Endow , Research Associate I, Drug Substance
Peter Farrell, Chairman of the Board
Peter Farrell, Chairman of the BoardBio
Adam Finochio, Research Associate I, Formulation Development
Adam Finochio, Research Associate I, Formulation Development
Cindy Fisher , Senior Director, Regulatory Affairs
Cindy Fisher , Senior Director, Regulatory Affairs
Daniel Garcia , Scientist I, Translational Biology
Daniel Garcia , Scientist I, Translational Biology
David Geller, Vice President, Clinical Development for Pulmonary and Rare Diseases
David Geller, Vice President, Clinical Development for Pulmonary and Rare DiseasesBio
Kyra Gillard, Research Associate II, Translational Biology
Kyra Gillard, Research Associate II, Translational Biology
Nicole Gillies , Executive Assistant
Nicole Gillies , Executive Assistant
Arjan Hada , Scientist II, Formulation
Arjan Hada , Scientist II, Formulation
Abraham Gomez, Senior Research Associate, Translational Biology
Abraham Gomez, Senior Research Associate, Translational Biology
Ayelet Gonen, Senior Scientist, Pharmacologist, Translational Biology
Ayelet Gonen, Senior Scientist, Pharmacologist, Translational Biology
Jose Gonzales, Senior Research Associate II & Vivarium Supervisor
Jose Gonzales, Senior Research Associate II & Vivarium Supervisor
Jennifer Goodfellow, Executive Director, Strategic Sourcing Head
Jennifer Goodfellow, Executive Director, Strategic Sourcing Head
Yurong Guo, Associate Director, Analytical Development and QC
Yurong Guo, Associate Director, Analytical Development and QC
Kyle Gutsadt, Analyst, Investor & Public Relations
Kyle Gutsadt, Analyst, Investor & Public Relations
Paula Hartman, Project Manager
Paula Hartman, Project Manager
JP Headley, Director, Accounting and Operations
JP Headley, Director, Accounting and Operations
Michael Hodges, R&D & Medical Consultant
Michael Hodges, R&D & Medical ConsultantBio
Dr. Ed Holmes, Director of the Board
Dr. Ed Holmes, Director of the BoardBio
Hyojung Hong, Research Associate I, Formulation Development
Hyojung Hong, Research Associate I, Formulation Development
Dr. Steve Hughes, Chief Medical Officer
Dr. Steve Hughes, Chief Medical OfficerBio
Hannah Huynh, Laboratory Coordinator
Hannah Huynh, Laboratory Coordinator
Daniel Hwang, Accounting Manager
Daniel Hwang, Accounting Manager
Hongfan Jin , Director, Bioanalytical
Hongfan Jin , Director, Bioanalytical
Lisa Kieweg-Thompson, Senior Research Associate, RNA Production
Lisa Kieweg-Thompson, Senior Research Associate, RNA Production
Michelle Kim, Research Associate II, Analytical Development
Michelle Kim, Research Associate II, Analytical Development
Mukunda Krishna, Senior Process Engineer II, Technical Transfer
Mukunda Krishna, Senior Process Engineer II, Technical Transfer
Kristen Kuakini, Research Associate II
Kristen Kuakini, Research Associate II
Greg Kubczak, Director, Technical Services and Manufacturing
Greg Kubczak, Director, Technical Services and Manufacturing
KC Kummerfeld, Vice President, Finance & Corporate Controller
KC Kummerfeld, Vice President, Finance & Corporate ControllerBio
Yi Kuo, Research Associate II
Yi Kuo, Research Associate II
Lance Kurata, Chief Legal Officer
Lance Kurata, Chief Legal OfficerBio
Annalee Ledesma, Associate Director, Program Management
Annalee Ledesma, Associate Director, Program Management
Angel Leu, Senior Research Associate II, Frontier Science
Angel Leu, Senior Research Associate II, Frontier Science
Pattraranee (Patty) Limphong, Associate Director, Drug Discovery
Pattraranee (Patty) Limphong, Associate Director, Drug Discovery
Kelly Lindert, Senior Vice President, Head of Vaccine Clinical Development
Kelly Lindert, Senior Vice President, Head of Vaccine Clinical DevelopmentBio
Jeremy Little , Process Engineer, RNA Production
Jeremy Little , Process Engineer, RNA Production
Rob Lopez, Facilities & Logistics Specialist
Rob Lopez, Facilities & Logistics Specialist
Tim Luger, Senior Research Associate I, Drug Substance
Tim Luger, Senior Research Associate I, Drug Substance
Brian Luk , Senior Scientist, Formulation Development
Brian Luk , Senior Scientist, Formulation Development
Quang Ly , Process Engineer II, Drug Product
Quang Ly , Process Engineer II, Drug Product
Dr. Jing L. Marantz, M.D., Ph.D, MBA, Director of the Board
Dr. Jing L. Marantz, M.D., Ph.D, MBA, Director of the BoardBio
Dr. Magda Marquet, Director of the Board
Dr. Magda Marquet, Director of the BoardBio
Daiki Matsuda, Associate Director, Frontier Science
Daiki Matsuda, Associate Director, Frontier Science
Alana Montoya, Senior Research Associate II, Drug Substance
Alana Montoya, Senior Research Associate II, Drug Substance
Rajesh Mukthavaram, Senior Scientist, Formulation Development
Rajesh Mukthavaram, Senior Scientist, Formulation Development
Kat Murphy, Director, Clinical Operations
Kat Murphy, Director, Clinical Operations
Andy Ngo, Research Associate II, RNA Production
Andy Ngo, Research Associate II, RNA Production
Jimmy Nguyen , Research Associate I, Formulation Development
Jimmy Nguyen , Research Associate I, Formulation Development
Michelle Nguyen, Manager, CMC Operations
Michelle Nguyen, Manager, CMC Operations
Raju Nilkanthache , Senior Manager, Stability
Raju Nilkanthache , Senior Manager, Stability
Maria Nunez , Associate Corporate Counsel
Maria Nunez , Associate Corporate Counsel
Cristine Ohlson, Contracts Administrator/Paralegal
Cristine Ohlson, Contracts Administrator/Paralegal
Ariel Olesco , Research Assistant, Formulation Development
Ariel Olesco , Research Assistant, Formulation Development
Mario Ornelas, Quality Manager, Quality & Regulatory
Mario Ornelas, Quality Manager, Quality & Regulatory
Jinho Park, Scientist I, Formulation Development
Jinho Park, Scientist I, Formulation Development
Suezanne Parker, Senior Vice President, Translational Biology
Suezanne Parker, Senior Vice President, Translational BiologyBio
Deep Patel, Manager, CMC Operations
Deep Patel, Manager, CMC Operations
Joseph E. Payne, President & CEO, Director of the Board
Joseph E. Payne, President & CEO, Director of the BoardBio
Yihua Pei, Scientist II, Formulation Development
Yihua Pei, Scientist II, Formulation Development
Carlos Perez-Garcia, Senior Scientist, Translational Biology
Carlos Perez-Garcia, Senior Scientist, Translational Biology
Gregory Peters , Clinical Trial Supply Chain
Gregory Peters , Clinical Trial Supply Chain
Edgardo Pica, Research Associate II, Analytical Development
Edgardo Pica, Research Associate II, Analytical Development
Linda Quirino, Senior Research Associate, Translational Biology
Linda Quirino, Senior Research Associate, Translational Biology
Huda Rabi, Research Associate II, Formulation Development
Huda Rabi, Research Associate II, Formulation Development
Kumar Rajappan, Senior Principal Scientist, Chemistry
Kumar Rajappan, Senior Principal Scientist, Chemistry
Tyler Raymer, Senior Manager, Facilities
Tyler Raymer, Senior Manager, Facilities
River Recatto, Research Associate I, Formulation Development
River Recatto, Research Associate I, Formulation Development
Paloma Martinez Redondo, Scientist II, Translational Biology
Paloma Martinez Redondo, Scientist II, Translational Biology
Pamela Resch, Executive Director, Quality and Regulatory Affairs
Pamela Resch, Executive Director, Quality and Regulatory Affairs
Josie Rivera, Research Associate I
Josie Rivera, Research Associate I
Joseph Roberts, Assistant Controller
Joseph Roberts, Assistant Controller
Fred del Rosario, Senior Director, Information Technology
Fred del Rosario, Senior Director, Information Technology
Deepankar Roy , Senior Director, Investor Relations
Deepankar Roy , Senior Director, Investor Relations
Sunil Raju, VP, Head of Drug Safety and Pharmacovigilance
Sunil Raju, VP, Head of Drug Safety and PharmacovigilanceBio
Qian Ruan, VP, Technical Operations & Manufacturing
Qian Ruan, VP, Technical Operations & ManufacturingBio
Cristiano Sacchetti, Senior Scientist, Bioanalytical
Cristiano Sacchetti, Senior Scientist, Bioanalytical
Hazel Santos, Accounts Payable Specialist
Hazel Santos, Accounts Payable Specialist
Andrew Sassine, Chief Financial Officer
Andrew Sassine, Chief Financial Officer
Noa Scott, Human Resources Specialist
Noa Scott, Human Resources Specialist
Kyle Scurlock, SEC Reporting Manager
Kyle Scurlock, SEC Reporting Manager
Rose Sekulovich, Executive Director, Bioanalytical
Rose Sekulovich, Executive Director, Bioanalytical
Anna Shishina , Scientist I, Analytical Development
Anna Shishina , Scientist I, Analytical Development
Donna Singh , Senior Document Specialist
Donna Singh , Senior Document Specialist
Ajit Simh, Senior Vice President, Head of Global Quality
Ajit Simh, Senior Vice President, Head of Global QualityBio
Henry Shafron, Research Associate I, Analytical Development
Henry Shafron, Research Associate I, Analytical Development
Matt Sharma, Senior Clinical Trial Manager
Matt Sharma, Senior Clinical Trial Manager
Kevin Skol, Senior Vice President, Business Development & Alliance Management
Kevin Skol, Senior Vice President, Business Development & Alliance ManagementBio
Claine Snow, Sr. IP & Transactions Counsel
Claine Snow, Sr. IP & Transactions Counsel
Benchawanna SoontornniyomkijI, Research Associate II, Translational Biology
Benchawanna SoontornniyomkijI, Research Associate II, Translational Biology
Tyler Spencer, Finance Manager
Tyler Spencer, Finance Manager
Brian Sullivan , Principal Scientist, Vaccines & Immunology
Brian Sullivan , Principal Scientist, Vaccines & Immunology
Sean Sullivan, Executive Director, Process Development
Sean Sullivan, Executive Director, Process Development
Kiyoshi Tachikawa, Senior Director, Frontier Science
Kiyoshi Tachikawa, Senior Director, Frontier Science
Viraj Talpade , Senior Manager, IT Infrastructure and Security
Viraj Talpade , Senior Manager, IT Infrastructure and Security
Wendy Taylor, Executive Director, Operations
Wendy Taylor, Executive Director, Operations
Phuong-Danh Tran, Research Associate I, Formulation Development
Phuong-Danh Tran, Research Associate I, Formulation Development
Ramon Diaz Trelles, Principal Scientist, Drug Discovery
Ramon Diaz Trelles, Principal Scientist, Drug Discovery
Andres Valderrama, Scientist II, Frontier Science
Andres Valderrama, Scientist II, Frontier Science
Dushyant Varshney, Executive Vice President & Chief Technology Officer
Dushyant Varshney, Executive Vice President & Chief Technology OfficerBio
Aishwarya Vasudevan , Research Associate II, Formulation Development
Aishwarya Vasudevan , Research Associate II, Formulation Development
Simone Ward, Senior IP Counsel, Life Science
Simone Ward, Senior IP Counsel, Life Science
Nancy Wilk , Benefits & Payroll Manager
Nancy Wilk , Benefits & Payroll Manager
Yuval Yarkoni , Senior Manager, Operational Technical Lead
Yuval Yarkoni , Senior Manager, Operational Technical Lead
Rodrigo Yelin, Associate Director, Program Management
Rodrigo Yelin, Associate Director, Program Management
Howard Yu, Senior Scientist, Bioanalytical
Howard Yu, Senior Scientist, Bioanalytical
Ye Zhang , Vice President, Head of Regulatory Strategy
Ye Zhang , Vice President, Head of Regulatory StrategyBio

Founded in 2013 and based in San Diego, California, Arcturus Therapeutics is an industry leader in the application of RNA technologies for the treatment of disease and improved quality of life. The company’s aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. Backed by a management team with extensive experience in the discovery and development of RNA medicines, Arcturus is on the forefront of research and development of RNA chemistry and delivery technologies.

 

News & Events
March 4, 2013
Arcturus Therapeutics Begins Operations in Janssen Labs
READ MORE
May 8, 2013
Arcturus Therapeutics Announces New Appointments to its Board of Directors and Scientific Advisory Board
READ MORE
June 1, 2013
Arcturus Therapeutics Raises $1.3 Million in Series Seed Funding
READ MORE
June 3, 2013
With $1.3M in Seed Funding, Arcturus Adds to RNAi Hub in San Diego
READ MORE
June 3, 2013
RNAi therapeutics startup sets up shop at Janssen labs, closes $1.3M seed round
READ MORE
June 3, 2013
Arcturus Therapeutics Raises $1.3 Million in Series Seed Funding
READ MORE
June 4, 2013
Janssen Labs-based Arcturus gets $1.3M boost for RNAi delivery tech
READ MORE
June 4, 2013
Arcturus Therapeutics Raises $1.3 Million in Series Seed Funding
READ MORE
June 4, 2013
Startup Arcturus Pulls in $1.3M in Seed Money amid Renewed Interest in RNAi
READ MORE
July 28, 2021
Arcturus Announces Regulatory Approval to Proceed with Phase 2 Study of ARCT-810 mRNA Therapeutic Candidate for Ornithine Transcarbamylase (OTC) Deficiency
READ MORE
August 2, 2021
Arcturus Therapeutics Collaborates with Vingroup to Establish Manufacturing Facility in Vietnam for Arcturus’ Investigational mRNA Vaccines for COVID-19
READ MORE
August 2, 2021
Arcturus Announces Approval of a Clinical Trial Application to Advance ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting the SARS-CoV-2 Delta Variant and Other Variants of Concern
READ MORE
August 3, 2021
Arcturus Announces Approval of Singapore Clinical Trial Application to Advance ARCT-154 and ARCT-165, Next Generation STARR™ mRNA Vaccines Targeting SARS-CoV-2 Variants of Concern, in a Phase 1/2 Study
READ MORE
August 9, 2021
Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress
READ MORE
September 7, 2021
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
READ MORE
September 8, 2021
Arcturus Therapeutics to Participate in Citi's 16th Annual BioPharma Virtual Conference 2021
READ MORE
September 22, 2021
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of Concern
READ MORE
September 22, 2021
Arcturus Therapeutics Announces Meeting with President of Vietnam and CEO of Vingroup to Discuss Expansion of COVID-19 Vaccine Collaboration
READ MORE
October 12, 2021
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 3b Study for ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of Concern
READ MORE
October 20, 2021
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
READ MORE
October 21, 2021
Arcturus Therapeutics Announces Leadership Appointments
READ MORE
October 25, 2021
Arcturus Therapeutics to Report Third Quarter 2021 Financial Results and Provide Corporate Update on November 8, 2021
READ MORE
November 8, 2021
Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progress
READ MORE
November 18, 2021
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
READ MORE
November 22, 2021
Arcturus Therapeutics to Participate in Piper Sandler 33rd Annual Healthcare Conference
READ MORE
December 13, 2021
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
READ MORE
December 16, 2021
Arcturus Therapeutics Reports New Data and Provides Additional Updates from ARCT-154 and ARCT-165 Clinical Trials
READ MORE
January 24, 2022
Arcturus Therapeutics Updates Data from ARCT-154 and ARCT-165 Booster Clinical Trial Demonstrating Robust Neutralizing Antibody Responses to SARS-CoV-2 and Several Variants
READ MORE
January 25, 2022
Arcturus Therapeutics Reports New Data Demonstrating Neutralizing Antibody Immune Response to the SARS-CoV-2 Omicron Variant from ARCT-154 and ARCT-165 Booster Clinical Trial
READ MORE
X